We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Comen Medical

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Venous Support System Improves CABG Outcomes

By HospiMedica International staff writers
Posted on 02 Dec 2021
Print article
Image: The venous external support (VEST) system (Photo courtesy of VGS)
Image: The venous external support (VEST) system (Photo courtesy of VGS)
A novel device could lead to increased longevity and durability of saphenous vein grafts (SVG) during coronary artery bypass graft (CABG) surgery, according to a new study.

The venous external support (VEST) system, under development by Vascular Graft Solutions (VGS; Tel Aviv, Israel) is a fine, kink-resistant cobalt-chromium wire mesh that is placed over a SVG to prevent non-uniform graft dilatation post-implantation, mitigate formation of disturbed blood flow patterns, and prevent subsequent development of intimal hyperplasia. Two models are available (VEST and VEST 2.0); VEST 2.0 is more pliable, as it is braided of thinner wires, and can be cut intraoperatively by the surgeon to fit desired SVG length.

The results of a recent randomized, controlled, clinical trial comparing VEST supported and non-supported vein grafts up to five years post CABG demonstrated that VEST can mitigate pathological remodeling of SVGs, significantly reduce intimal hyperplasia and lumen irregularities, and improves blood flow hemodynamics. The study was presented as a late-breaking clinical trial during the virtual American Heart Association Scientific Sessions, broadcast from Dallas (TX, USA) during November 2021.

“Vein grafts have a limited durability; about half of them will be closed ten years after CABG. We need to find a solution to improve outcomes of surgery and prevent complications and repeated procedures,” said lead author and study presenter John Puskas, MD, chair of cardiovascular surgery at Mount Sinai Morningside (NY, NY, USA). “Among patients with complete intravascular ultrasound data, VEST was associated with statistically reduced intimal hyperplasia.”

SVGs are the most frequently used bypass conduits in CABG surgery. But saphenous veins normally experience low pressure in the leg; the higher-pressure environment of the coronary arteries can cause intimal hyperplasia, which promotes atherosclerosis and may lead to eventual closure. SVG failure rates range from 35% to 50% (five to ten years following CABG surgery), doubling the risk for re-intervention.

Related Links:
Vascular Graft Solutions

Print article


Critical Care

view channel
Image: ID NOW (Photo courtesy of Abbott)

Abbott Displays Its Life-Changing POC Tests and Diagnostic Tools at MEDLAB Middle East

At the 2022 edition of MEDLAB Middle East, Abbott (Lake Forest, IL, USA) showcased its portfolio of life-changing diagnostic tools and medical devices for point-of-care testing that help manage patients... Read more


view channel

IBM Sells Watson Health Assets to Focus on Platform-Based Hybrid Cloud and AI Strategy

IBM (Armonk, NY, USA) and Francisco Partners (San Francisco, CA, USA) have signed a definitive agreement under which Francisco Partners will acquire healthcare data and analytics assets from IBM that are... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.